Everything

 

Home

Metzger Law Group Free Case Evaluation Twitter Facebook RSS 1-877-tox-tort Home About Us The Law Firm California's Toxic Tort Law Firm Mission Statement Employment Opportunities Facilities Location Directions Map Attorneys Gregory Coolidge Sarah Hodgson Kenneth Holdren Lisa Ishimaru Raphael Metzger

St. Jude Finds More than 100 Gene Variations Linked with Response to Leukemia Treatment

Scientists from St. Jude Children’s Research Hospital and the Children’s Oncology Group (COG) have discovered, in children with acute lymphoblastic leukemia (ALL), scores of inherited genetic variations that clinicians might be able to use as guideposts for designing more effective chemotherapy for

Monoclonal Antibodies against Nucleophosmin Mutants: Potentials for the Detection of Acute Myeloid

<p>Nucleophosmin (<i>NPM1</i>) gene mutations resulting in cytoplasmic delocalization of Nucleophosmin (NPMc+) are the most common genetic alteration in acute myeloid leukemia (AML). Here, we attempted to prepare monoclonal antibodies (mAbs) against <i>NPM1 </i>mutation A (NPM-mA) and investigated

Trial Attorney Jason Guari Elected on Board of Trustees for the Leukemia and Lymphoma Society

Trial Attorney Jason Guari Elected on Board of Trustees for the Leukemia and Lymphoma Society. Trial Attorney Jason Guari of the law firm of Murray & Guari elected on 2010 -2011 Board of Trustees for the Leukemia & Lymphoma Society’s (LLS) – Palm Beach Area Chapter. July 1, 2010 marked the

Tamibarotene eradicates advanced-stage leukemia | Pharma Asia

CytRx announces that an advanced form of acute promyelocytic leukemia, or APL, has been eradicated in former NBA player Ray Johnston following treatment with CytRx’s experimental cancer drug tamibarotene. Johnston was afflicted with a particularly aggressive type of APL called chloromas and had

CHRONIC LYMPHOCYTIC LEUKEMIA THERAPEUTICS MARKET (2010 - 2020) (Pipeline Assessment & Market

SYS-CON Media, NJ, The world's leading i-technology media company on breaking technology news.

Pediatric leukemia revealed by a limping episode: A report of four cases - EM|consulte

Orthopaedics & Traumatology: Surgery & Research - Vol. 95 - N° 1 - p. 77-81 - Pediatric leukemia revealed by a limping episode: A report of four cases - EM|consulte

Arsenic for Leukemia - Watch WebMD Video

September is leukemia and lymphoma awareness month. And believe it or not, old-fashioned rat poison is helping some leukemia patients battle their cancer.

Combination Therapy Targets Stubborn Leukemia Stem Cells, City of Hope Study - News, Search Jobs,

ScienceDaily (May 17, 2010) New research discovers a combination of drugs that may prove to be a more effective treatment for a lethal form of leukemia. The study, published by Cell Press in the May issue of the journal Cancer Cell, reports that the new therapeutic strategy effectively targets

Medical News: Extra Helping of AML Drug Risky for Tx Induction - in Oncology/Hematology, Leukemia

A high induction dose of cytarabine for acute myeloid leukemia (AML) may add to toxicity without improving outcomes, researchers found.

Results 1-10 of 279
 


Refine by Content Type:



Refine by Source:

33 Sources ...